Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

International Myositis Assessment and Clinical Studies Guidelines for Risk-Based Cancer Screening: An External Validation in Patients With Dermatomyositis Seen at a Metropolitan Academic Center.

ACR open rheumatology·2026
Same author

Dual Therapy for Atopic Dermatitis: Lebrikizumab and JAK inhibitors used in Tandem for Treatment-Resistant Cases.

Journal of drugs in dermatology : JDD·2026
Same author

Off-label Use of Nemolizumab to Address Pruritic Skin Disease: A Case Series in Dermatomyositis Patients.

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases·2026
Same author

Efficacy of Tralokinumab in Atopic Dermatitis Patients With Prior Biologic and JAK Inhibitor Therapy.

International journal of dermatology·2026
Same author

Bimekizumab efficacy using IHS4 outcomes in hidradenitis suppurativa: Results from BE HEARD I and II.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026
Same author

Treatment of Generalized Granuloma Annulare With Biologics and Oral JAK Inhibitors: A Case Series.

Journal of drugs in dermatology : JDD·2026
Same journal

Emapalumab plus conventional therapy with or without ruxolitinib for pediatric hemophagocytic lymphohistiocytosis: a single center retrospective study.

Immunologic research·2026
Same journal

Immunological spectrum in patients with thymoma: beyond good syndrome.

Immunologic research·2026
Same journal

Microbiome immune crosstalk in Sjögren's syndrome: mechanistic insights and translational perspectives.

Immunologic research·2026
Same journal

Immune checkpoint inhibitor-induced myasthenia gravis and myocarditis: a fatal immune-related adverse event.

Immunologic research·2026
Same journal

TRIM28 and TRIM32: multifaceted regulators of innate immunity and antiviral defence.

Immunologic research·2026
Same journal

Decoding PANoptosis: Crosstalk of cell death pathways in immunity and inflammation.

Immunologic research·2026
See all related articles

Related Experiment Video

Updated: May 12, 2026

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

Statins and autoimmunity.

Saakshi Khattri1, Gisele Zandman-Goddard

  • 1Department of Rheumatology, Albert Einstein College of Medicine, Bronx, NY, USA.

Immunologic Research
|April 11, 2013
PubMed
Summary
This summary is machine-generated.

Statins, with their immune-modulating properties, show promise as add-on treatments for autoimmune diseases. Research indicates potential benefits in managing rheumatoid arthritis, lupus, and atherosclerosis prevention.

Related Experiment Videos

Last Updated: May 12, 2026

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

Area of Science:

  • Immunology
  • Rheumatology
  • Cardiology

Background:

  • Statins possess immunomodulatory effects beyond their lipid-lowering capabilities.
  • Autoimmune diseases are often associated with accelerated atherosclerosis and inflammatory processes.
  • Current treatments for autoimmune diseases may benefit from adjunct therapies targeting inflammation and thrombosis.

Purpose of the Study:

  • To review the mechanisms by which statins modulate the immune system.
  • To evaluate the existing literature on the benefits of statins in various autoimmune diseases.
  • To explore the potential role of statins in preventing cardiovascular complications in autoimmune patients.

Main Methods:

  • Systematic review of preclinical and clinical studies investigating statin use in autoimmune conditions.
  • Analysis of studies focusing on immune regulation pathways affected by statins.
  • Literature search for evidence of statin efficacy in disease activity, prothrombotic factors, and cardiovascular events.

Main Results:

  • Statins demonstrated improvements in disease activity scores for rheumatoid arthritis and ankylosing spondylitis.
  • Reductions in prothrombotic factors were observed in anti-phospholipid syndrome patients.
  • Beneficial effects on vasculature, proteinuria, and cardiac events were noted in systemic lupus erythematosus and vasculitis patients.

Conclusions:

  • Statins exhibit anti-inflammatory, immunomodulatory, and anti-thrombogenic effects beneficial in autoimmune diseases.
  • Statins show potential as adjunct therapy for managing disease activity and cardiovascular risk in autoimmune populations.
  • Further evidence-based research is necessary to establish statins as a standard of care for autoimmune diseases.